Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Mental Disease

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1773866

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1773866

Postpartum Depression Drugs

PUBLISHED:
PAGES: 479 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Postpartum Depression Drugs Market to Reach US$1.4 Billion by 2030

The global market for Postpartum Depression Drugs estimated at US$894.9 Million in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Postpartum Anxiety, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$300.5 Million by the end of the analysis period. Growth in the Postpartum Blues segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$243.8 Million While China is Forecast to Grow at 11.8% CAGR

The Postpartum Depression Drugs market in the U.S. is estimated at US$243.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$294.2 Million by the year 2030 trailing a CAGR of 11.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Postpartum Depression Drugs Market - Key Trends & Drivers Summarized

What Are the Latest Innovations Reshaping the Postpartum Depression Treatment Landscape?

The postpartum depression (PPD) drugs market has seen a significant transformation in recent years, driven by advancements in pharmaceutical research and increased awareness of maternal mental health. Traditional antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) have long been the standard of care. However, the recent approval of rapid-acting medications like brexanolone (Zulresso) and zuranolone has marked a paradigm shift in treatment approaches. Unlike conventional antidepressants, which take weeks to show effectiveness, these new medications provide relief within hours or days, addressing the urgent need for faster-acting solutions in severe cases of PPD.

Additionally, there is growing interest in the role of neurosteroid-based therapies, which target the gamma-aminobutyric acid (GABA) receptors, a mechanism that differs from traditional antidepressants. Researchers are also exploring personalized medicine approaches, leveraging genetic and biomarker-driven data to tailor drug treatments based on individual patient profiles. The increased use of telemedicine and digital health tools further enhances access to these innovative treatments, making PPD care more efficient and patient-centered.

How Are Market Trends and Consumer Awareness Shaping Demand?

The demand for postpartum depression drugs is rising globally, fueled by increasing recognition of maternal mental health issues and evolving healthcare policies. Governments and healthcare organizations worldwide are investing in awareness campaigns to reduce the stigma surrounding PPD and encourage affected individuals to seek medical intervention. The expansion of reimbursement policies for mental health treatments has also played a crucial role in driving prescription rates for PPD medications.

Furthermore, the pharmaceutical industry is witnessing a surge in research collaborations aimed at developing novel drug formulations. For instance, the push for non-invasive delivery methods such as nasal sprays, transdermal patches, and sublingual tablets is gaining momentum, offering more convenient alternatives to traditional intravenous (IV) or oral medications. The growing acceptance of holistic treatment approaches, which integrate pharmacological interventions with cognitive-behavioral therapy (CBT) and lifestyle modifications, is also shaping consumer preferences. As more women become proactive about their mental health, the adoption of effective PPD drugs is expected to rise significantly.

Why Is North America Leading the Market, and What Are the Regional Dynamics?

North America, particularly the United States, dominates the postpartum depression drugs market due to strong healthcare infrastructure, high awareness levels, and robust pharmaceutical research and development activities. The region benefits from a well-established regulatory framework that expedites the approval and commercialization of innovative drugs. The presence of key industry players, such as Sage Therapeutics and Biogen, has also contributed to rapid advancements in drug development. Additionally, the U.S. Food and Drug Administration (FDA) has taken proactive measures to fast-track the approval of novel PPD treatments, ensuring quicker market access for patients in need.

On the other hand, Europe follows closely behind, driven by increased government initiatives promoting maternal mental health and improved healthcare access. Countries such as Germany, the UK, and France have witnessed a steady rise in prescription rates for PPD drugs, supported by national healthcare programs that cover mental health treatments. Meanwhile, the Asia-Pacific region is emerging as a lucrative market due to rising awareness, increasing healthcare expenditure, and expanding pharmaceutical distribution networks. However, cultural stigmas surrounding mental health in several Asian and Middle Eastern countries continue to pose challenges to market penetration, highlighting the need for targeted awareness initiatives and policy reforms.

The Growth in the Postpartum Depression Drugs Market Is Driven by Several Factors

One of the key drivers is the advancement in neurosteroid-based therapeutics, which offer faster relief compared to traditional antidepressants. The recent breakthroughs in GABA receptor modulators have provided a much-needed alternative for women who experience severe postpartum depression, leading to increased adoption of these novel drugs. Furthermore, the integration of artificial intelligence (AI) in drug discovery is accelerating the development of more effective and targeted treatments, enhancing drug efficacy while minimizing side effects.

Another crucial factor fueling market growth is the increasing investment in women’s health initiatives. Governments and private organizations are allocating substantial funds toward maternal mental health programs, leading to greater accessibility to postpartum depression medications. Additionally, pharmaceutical companies are actively expanding their clinical research efforts to explore new drug formulations with improved safety profiles. The rising adoption of digital therapeutics and telepsychiatry is also significantly influencing the market, providing patients with better access to healthcare professionals and medication management services.

Moreover, the expansion of retail and online pharmacy distribution channels is streamlining the availability of PPD drugs, ensuring that patients in both urban and rural areas have better access to treatment. As regulatory agencies continue to support fast-track approvals for innovative drug solutions, the postpartum depression drugs market is expected to witness sustained growth in the coming years, driven by a convergence of technological, therapeutic, and consumer-driven factors.

SCOPE OF STUDY:

The report analyzes the Postpartum Depression Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder, Postpartum Psychosis); Treatment Type (Pharmacotherapy, Hormonal Therapy, Other Treatment Types); Administration Route (Parenteral Administration, Oral Administration, Other Administration Routes); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • AbbVie Inc.
  • Allergan plc
  • AstraZeneca plc
  • Bayer AG
  • Biogen Inc.
  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • H. Lundbeck A/S
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Sage Therapeutics, Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Ltd.
  • Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP32647

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Postpartum Depression Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Awareness of Postpartum Depression Drives Demand for Specialized Pharmaceutical Solutions
    • Rising Prevalence of Postpartum Depression among New Mothers Spurs Growth in the Market for Postpartum Depression Drugs
    • Regulatory Approvals of New Postpartum Depression Drugs Accelerate Market Expansion
    • Emergence of Novel Drug Classes for Postpartum Depression Strengthens the Business Case for Market Growth
    • Advancements in Personalized Medicine for Postpartum Depression Treatment Expands Addressable Market Opportunity
    • Growing Focus on Mental Health and Maternal Well-being Drives Adoption of Postpartum Depression Medications
    • Expanding Healthcare Access in Emerging Markets Increases the Reach of Postpartum Depression Drugs
    • Rising Investments in Womens Mental Health and Postpartum Care Enhances Market Opportunities for Pharmaceutical Companies
    • Increasing Recognition of Postpartum Depression as a Serious Health Concern Generates Demand for Effective Treatment Solutions
    • Development of Non-Pharmacological Treatments for Postpartum Depression Strengthens the Market Landscape
    • Integration of Digital Health Platforms for Postpartum Depression Management Expands Treatment Options
    • Impact of Telemedicine and Remote Monitoring on Postpartum Depression Treatment Propels Growth in Drug Adoption
    • Shift Towards Integrated Healthcare Solutions for Maternal Mental Health Drives Increased Drug Utilization
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Postpartum Depression Drugs Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Postpartum Depression Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Postpartum Depression Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Postpartum Anxiety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Postpartum Anxiety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Postpartum Anxiety by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Postpartum Blues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Postpartum Blues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Postpartum Blues by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Postpartum Obsessive-Compulsive Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Postpartum Obsessive-Compulsive Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Postpartum Obsessive-Compulsive Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Postpartum Post-Traumatic Stress Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Postpartum Post-Traumatic Stress Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Postpartum Post-Traumatic Stress Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Postpartum Panic Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Postpartum Panic Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Postpartum Panic Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Postpartum Psychosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Postpartum Psychosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Postpartum Psychosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Administration Routes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Pharmacotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Pharmacotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Pharmacotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Hormonal Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Hormonal Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Hormonal Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: USA 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Canada 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Japan 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • CHINA
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 86: China Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: China 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: China 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Postpartum Depression Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Postpartum Depression Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Europe 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Europe 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 113: France Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 119: France Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: France 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: France 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Germany 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Germany 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Italy 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Italy 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 149: UK Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 155: UK Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: UK 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: UK 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Spain 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Spain Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Spain 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Spain Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Spain 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Russia 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Russia Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Russia 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Russia Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Russia 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Postpartum Depression Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Australia 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Australia Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Australia 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Australia Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Australia 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • INDIA
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 224: India Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 227: India Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: India 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 230: India Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: India Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: India 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 233: India Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: India Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: India 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: South Korea 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: South Korea Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: South Korea 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: South Korea Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: South Korea 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Postpartum Depression Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Postpartum Depression Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Latin America 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Latin America Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Latin America 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Latin America 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Argentina 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Argentina Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Argentina 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Argentina Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Argentina 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Brazil 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Brazil Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Brazil 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Brazil Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Brazil 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Mexico 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Mexico Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Mexico 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Mexico Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Mexico 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Rest of Latin America 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Rest of Latin America 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Postpartum Depression Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Postpartum Depression Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Middle East 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Middle East Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Middle East 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Middle East 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Iran 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Iran Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Iran 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Iran Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Iran 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Israel 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Israel Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Israel 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Israel Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: Israel 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: Saudi Arabia 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: Saudi Arabia 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: UAE 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: UAE Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: UAE 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: UAE Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: UAE 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Rest of Middle East 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 397: Rest of Middle East 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 403: Africa 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Africa Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 406: Africa 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Africa Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 409: Africa 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!